Subsequent research revealed that liver cancer spheroids rich in patient-derived CSC as well as cancer stem cells (CSCs) selected for epithelial cell adhesion molecule (EpCAM) or differentiation cluster 133 (CD133) showed a substantial increase in SHP2. Here, EPCAM is linked to cancer.